Bill Status of HB 2631   103rd General Assembly


Short Description:  MEDICAID-HEPATITIS C-TREATMENT

House Sponsors
Rep. Marcus C. Evans, Jr.

Last Action  View All Actions

DateChamber Action
  5/19/2023HouseRule 19(a) / Re-referred to Rules Committee

Statutes Amended In Order of Appearance
305 ILCS 5/5-5.12f new

Synopsis As Introduced
Amends the Medical Assistance Article of the Illinois Public Aid Code. Provides that for the purpose of removing barriers to the timely and equitable treatment of hepatitis C, prior authorization mandates and utilization management controls shall not be imposed under the fee-for-service and managed care medical assistance programs on any FDA-approved direct-acting antivirals for the treatment of hepatitis C that are listed as preferred on the Illinois Medicaid Preferred Drug List.

Actions 
DateChamber Action
  2/15/2023HouseFiled with the Clerk by Rep. Marcus C. Evans, Jr.
  2/15/2023HouseFirst Reading
  2/15/2023HouseReferred to Rules Committee
  2/28/2023HouseAssigned to Appropriations-Health & Human Services Committee
  3/9/2023HouseTo Medicaid & Managed Care Subcommittee
  3/10/2023HouseCommittee/3rd Reading Deadline Extended-Rule May 19, 2023
  5/19/2023HouseRule 19(a) / Re-referred to Rules Committee

Back To Top